Predicting suitable ligands as drug candidates for Amyloid Precursor Protein (APP) targetin the treatment of Alzheimer's Disease

Alzheimer’s Disease (AD) is characterized by deposition of Amyloid-Beta Peptide (Aβ), which isproduced from post-translational processing of Amyloid Precursor Protein (APP) so biochemical and geneticstudies of APP processing will be crucial to the development of therapeutic targets to treat AD. The goal of thisresearch is to predict suitable ligands as drug candidates for APP target in the treatment of Alzheimer's disease.

کلیدواژه ها:

Alzheimer’s Disease (AD) ، APP target ، drug discovery